Widespread rescue missions for survivors have continued after devastating earthquakes rocked Venezuela.
READ MORENATO fighters were scrambled over Lithuania today after a kamikaze drone was feared to have entered its airspace.
It's a banger of a half-time meal.
Be One of the First to Uncover the Secrets and Delve into the Mysteries of Luminora SEOUL,South Korea,Nov. 5,2024-- Global game development and publishing company Smilegate today announced that their
Challenges traditional view of transition from nomadicpastoralism to nascent urbanism ALULA,Saudi Arabia,Nov. 2,2024-- New archaeological research has revealed an exceptional Bronze Age town in theKh
SEOUL,South Korea,Nov. 4,2024-- Shinsegae Duty Free,in collaboration with Chanel,has unveiled the largest Chanel Winter Tale podium in the Asia-Pacific (APAC) duty-free at Incheon Airport Terminal 2.
After Singapore,Seoul and Tokyo,entry into Taiwan region brings the DC platform\'s footprint to 4 markets in Asia reaching nearly 70MW of IT co-location capacity in prime locations
MELBOURNE,Australia,Nov. 4,2024-- Bizcap,a leader in fast and flexible business finance across Australia,New Zealand,and the U.K.,is thrilled to announce its upcoming Singapore expansion and the appoi
From 1 April 2025,DAZN will be the exclusive global broadcast partner of Queensberry Promotions,bringing its elite boxing events to fans worldwide for the first time.
BEIJING,Nov. 4,2024-- Geek+,in collaboration with Intel,launched the world\'s first Vision Only Robot Solution equipped with the Intel Visual Navigation Modules,driving the digital and intelligent tra
TOKYO,Oct. 31,2024-- KLab Inc.,a leader in online mobile games,announced that its hit 3D action game Bleach: Brave Souls will be holding the Anime Broadcast Celebration Special: Thousand-Year Blood Wa
MUNICH,Oct. 31,2024--Nagarro,a leader in digital engineering,today announced a global partnership with Marubeni Corporation,one of Japan\'s largest general trading companies. This collaboration aims t
CHENGDU,China,Oct. 31,2024-- The new drug application (NDA) (the "Application") based on the positive results from the pivotalphase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-
© OfficialAffairs
